Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2016 | Prevention strategies for Alzheimer’s disease

Philip Scheltens • 29 May 2016
EAN 2016
Alzheimer’s Disease

At the 2nd Congress of the European Academy of Neurology (EAN), held in Copenhagen, Denmark, from May 28–31 2016, Philip Scheltens, MD, PhD, from VU University Medical Center, Amsterdam, the Netherlands, discusses the clinical development of prevention strategies, including for reducing the development amyloid plaques in preclinical stages, for patients with Alzheimer’s disease.

More from Philip Scheltens

1:03
Alzheimer's early diagnosis: challenges and benefits
Philip Scheltens • 19 Mar 2019
0:46
The heterogeneity of Alzheimer's disease
Philip Scheltens • 19 Mar 2019
1:45
A biological definition of Alzheimer's disease
Philip Scheltens • 19 Mar 2019
1:06
Cerebrospinal fluid (CSF) and imaging biomarkers for the differential diagnosis of dementia
Philip Scheltens • 24 Jun 2017

Related Videos

3:58
Promising FONLISA test for ultrasensitive detection of plasma NfL in Alzheimer’s disease
Madison Honey • 7 Mar 2024
4:12
Updates in Alzheimer’s treatment: the potential of NSC001
Manfred Windisch • 6 Mar 2024
4:44
Influence of genetic risk for psychiatric disorders on dementia
Jenna Najar • 6 Mar 2024
2:06
The role of governments in addressing the access issues to dementia treatment
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals